Home / Companies / Nutriventia

Nutriventia

Nutraceutical IngredientsMumbai, India

Nutriventia is a Mumbai nutraceutical ingredients company developing clinically validated, branded ingredients built on proprietary delivery technologies aimed at bioavailability, stability and dosing. Its portfolio includes the turmeric ingredient TurmXTRA, CaffXtend, Melotime, the ashwagandha ingredient Ashwanova (Prolanza) and C-Fence, with the alpha lipoic acid ingredient ALAXTRA in development, and it supplies formulators and wellness brands across the United States, Europe, Australia, South Korea and Japan. It is led by co-founder and managing director Vishal Shah and co-founder Rajat Mi

1StartupFox story
Nutraceutical IngredientsSector
Oct 2026Latest coverage

Funding

—Raised (money in)
Strategic growth investmentLatest round · September 2026
1Event
September 2026Strategic growth investment—NDude Labs

The rest of Nutriventia's profile is free

Every funding round with its source, verified financials, leadership and the full journey timeline — sign in once and it stays unlocked.

One tap. No newsletter unless you ask for it.

Latest on Nutriventia

Also in Healthcare

Frequently Asked

What is Nutriventia?

Nutriventia is a Mumbai nutraceutical ingredients company developing clinically validated, branded ingredients built on proprietary delivery technologies aimed at bioavailability, stability and dosing. Its portfolio includes the turmeric ingredient TurmXTRA, CaffXtend, Melotime, the ashwagandha ingredient Ashwanova (Prolanza) and C-Fence, with the alpha lipoic acid ingredient ALAXTRA in development, and it supplies formulators and wellness brands across the United States, Europe, Australia, South Korea and Japan. It is led by co-founder and managing director Vishal Shah and co-founder Rajat Mi

Who founded Nutriventia?

Nutriventia's founders and leadership on record at StartupFox are Vishal Shah and Rajat Mittal Shah.

What is the latest news on Nutriventia?

The most recent StartupFox coverage is “India's NDude Labs Leads $3M in SuperMush, Betting on Both Ends of the Supplement Aisle” (6 October 2026). All stories are listed on this page.

Sources & updates

This profile is compiled by the StartupFox desk from company announcements, regulatory and exchange filings (RoC/MCA, NSE/BSE) and our own reporting. 0 of 1 funding round links to a named source.

Last updated
How we verify
Sourcing standards
Spot an error?
Request a correction